£13.2M
The biotechnology company has obtained grant funding to advance its antibacterial therapy through Phase 1 clinical trials.
PT
Phico Therapeutics
Developing engineered phage technology to create new antibacterial treatments.
Cambridge, UK—Founded 2000
£13.2MTotal raised
Phico Therapeutics is a biotechnology company developing engineered phage technology to create a new generation of antibiotics.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from Phico Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
